Welcome to LookChem.com Sign In|Join Free
  • or
Fmoc-L-Arg(Pmc)-OH is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

119831-72-0

Post Buying Request

119831-72-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

119831-72-0 Usage

Chemical Properties

White to off-white powder

Uses

Fmoc-Arg(Pmc)-OH (CAS# 119831-72-0) is an fmoc-protected form of L-Argenine used in the synthesis of peptides and peptide fragments, such as in the synthetic preparation of TGR5 agonists.

Check Digit Verification of cas no

The CAS Registry Mumber 119831-72-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,9,8,3 and 1 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 119831-72:
(8*1)+(7*1)+(6*9)+(5*8)+(4*3)+(3*1)+(2*7)+(1*2)=140
140 % 10 = 0
So 119831-72-0 is a valid CAS Registry Number.

119831-72-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name FMOC-L-arginine

1.2 Other means of identification

Product number -
Other names Fmoc-Arg(Pmc)-OH

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:119831-72-0 SDS

119831-72-0Downstream Products

119831-72-0Relevant academic research and scientific papers

Treatment of obesity

-

, (2008/06/13)

A method for the treatment of obesity in an animal such as a human, comprises administering to the animal an effective amount of a peptide which comprises an analogue of the carboxyl-terminal sequence of a growth hormone, particularly an analogue of the carboxyl-terminal sequence of human growth hormone containing amino acid residues 177-191. A pharmaceutical composition for use in the treatment of obesity is also disclosed.

GLP-2 compounds, formulations, and uses thereof

-

, (2008/06/13)

The present invention relates to novel human glucagon-like peptide-2 (GLP-2) peptides and human glucagon-like peptide-2 derivatives which have a protracted profile of action as well as polynucleotide constructs encoding such peptides, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.

An acid labile arginine derivative for peptide synthesis: N(G)-2,2,5,7,8-pentamethylchroman-6-sulphonyl-L-arginine

Ramage,Green,Blake

, p. 6353 - 6370 (2007/10/02)

A trifluoroacetic acid (TFA) labile protecting group for the guanidine side chain function of arginine has been developed. N(G)-(2,2,5,7,8-Pentamethylchroman-6-sulphonyl-L-arginine is cleaved rapidly in TFA or 50% TFA in dichloromethane at room temperatur

APPLICATION OF THE NG-(2,2,5,7,8-PENTAMETHYLCHROMAN-6-SULPHONYL) DERIVATIVE OF FMOC-ARGININE TO PEPTIDE SYNTHESIS

Green, J.,Ogunjobi, O. M.,Ramage, R.,Stewart, A. S. J.

, p. 4341 - 4344 (2007/10/02)

The trifluoroacetic acid labile pentamethylchromanylsulphonyl protecting group for the guanidino group of arginine has been used in conjunction with the base-labile Fmoc Nα protecting group for the synthesis of arginine-containing peptides.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 119831-72-0